Obesity-drug makers haven’t been shy about suing players encroaching on their turf. But a new round of lawsuits from Eli Lilly may signal a changing landscape for the space, right as a new potential blockbuster drug prepares to come on the scene.
The strains of ACA Marketplace price hikes and more uninsured patients were on display in hospital system earnings reports. More financial trouble from coming Medicaid cuts are imminent.
Major companies across the pharmaceutical and insurance industries posted their second quarter results this past week. Law360 looks at what you need to know.
Previous
Next
Obesity-drug makers haven’t been shy about suing players encroaching on their turf. But a new round of lawsuits from Eli Lilly may signal a changing landscape for the space, right as a new potential blockbuster drug prepares to come on the scene.
The strains of ACA Marketplace price hikes and more uninsured patients were on display in hospital system earnings reports. More financial trouble from coming Medicaid cuts are imminent.
Major companies across the pharmaceutical and insurance industries posted their second quarter results this past week. Law360 looks at what you need to know.
-
August 18, 2026
Jones Day-advised BioMarin Pharmaceutical Inc. said Tuesday it has agreed to acquire Alesta Therapeutics for $275 million upfront and up to another $215 million tied to the development and regulatory progress of Alesta's lead drug candidate.
-
August 18, 2026
A former Treace Medical Concepts executive was arrested on insider trading charges Tuesday, after New York federal prosecutors said he exploited secret warnings about the Florida medical device company's sales and turned a $37,000 profit betting its stock would fall.
-
August 17, 2026
Co-Diagnostics Inc. has agreed to pay $6.5 million to settle an investor lawsuit accusing it of overstating the demand for its COVID-19 testing kits two years after the pandemic began.
-
August 13, 2026
The North Carolina Business Court dropped a host of heavy-hitting opinions in July ahead of two judicial retirements and a new chief judge rising in the ranks.
-
August 11, 2026
A slew of big names posted their financial results this past week, closing out the earnings season for the second quarter.
-
August 10, 2026
A Colorado federal judge has declined to toss a shareholder class action against current and former executives of patient transportation company ModivCare Inc. over their alleged failure to disclose the negative impact of certain contract renegotiations, finding that the investors pled actionable misstatements.
-
August 10, 2026
The Delaware Chancery Court on Monday refused to block two former behavioral health facility owners from pursuing a California securities fraud suit against private equity firm H.I.G. Capital LLC and its affiliates, finding the companies had not shown the dispute must be litigated in Delaware.
-
August 10, 2026
Alto Neuroscience has escaped a shareholder suit alleging the psychiatric biotech company and its top brass overstated the efficacy of their lead drug candidate for treating major depressive disorder, with a California federal judge ruling that the suit's "vague and conclusory" pleadings should be remedied.
-
August 07, 2026
In this week's Taxation With Representation, U.K. real estate investment trust Segro's board agrees to a share offer from U.S. rival Prologis with a partial cash alternative, Curium acquires fellow radiopharmaceutical company Lantheus Holdings Inc., and investment firm KKR buys medical device company Integer Holdings Corp.
-
August 06, 2026
A Washington, D.C., federal judge on Thursday largely sided with the U.S. Securities and Exchange Commission in its civil enforcement case against the former CEO of RTI Surgical Holdings, finding he misled investors by failing to disclose that the surgical implant company regularly shipped orders early to artificially inflate its quarterly revenues.
-
August 06, 2026
A Connecticut federal judge has set a February trial date on claims from dozens of state attorneys general that generic-drug makers conspired to artificially inflate the prices of generic topical drugs.
-
August 06, 2026
Tarsus Pharmaceuticals Inc. said Thursday it has agreed to acquire privately held Alkeus Pharmaceuticals Inc. for up to approximately $800 million, expanding the Irvine, California-based eye care company's pipeline into retinal disease with an experimental treatment for Stargardt disease.
-
August 05, 2026
The Delaware Chancery Court has adopted a hybrid method for calculating prejudgment interest in the long-running merger dispute between Shareholder Representative Services LLC and Alexion Pharmaceuticals Inc., rejecting both sides' competing approaches.
-
August 04, 2026
Procter & Gamble is acquiring supplements company Thorne from L Catterton for $3.8 billion in cash, with Kirkland & Ellis LLP and Jones Day serving as legal advisers in the transaction, the companies announced Tuesday.
-
August 04, 2026
Catalyst Healthcare Real Estate and investment management firm Nuveen have linked up for a joint venture that will inject $400 million worth of equity into the medical property developer's pipeline of upcoming projects, the companies said Tuesday.
-
August 03, 2026
Private equity-backed radiopharmaceutical company Curium on Monday announced plans to acquire fellow radiopharmaceutical company Lantheus Holdings Inc. in an $8 billion take-private deal built by four law firms.
-
August 03, 2026
Sandoz reached a settlement with a coalition of state enforcers on Monday, agreeing to pay $450 million to end claims against it in several cases targeting alleged price-fixing in the generic-drug industry.
-
August 03, 2026
KKR said Monday that it will acquire medical device company Integer Holdings Corp. in an all-cash transaction with a roughly $5.7 billion enterprise value, with Kirkland & Ellis LLP and Davis Polk & Wardwell LLP advising on the transaction.
-
July 31, 2026
Law360 is pleased to announce the Rising Stars of 2026, our list of more than 160 attorneys under 40 whose legal accomplishments belie their age.
-
July 31, 2026
Insulin product developer Insulet Corp. has asked the full Federal Circuit to hear its arguments for reinstating a jury's $59.4 million trade secret theft verdict against EOFlow Co. Ltd., saying a split panel decision overturning the award reached a timeliness issue that was not mentioned by either party.
-
July 29, 2026
The North Carolina Business Court has cleared a path to trial in the state attorney general's suit accusing HCA Healthcare of letting the quality of care at Mission Hospital in Asheville languish.
-
July 28, 2026
Healthcare providers and drugmakers posted results for the second quarter of 2026 this past week, giving investors a closer look at how the first half of the year has played out. Law360 has what you need to know.
-
July 28, 2026
A Pennsylvania federal judge has taken Teva to task for trying to avoid being held to its admissions of price-fixing in a $225 million settlement with the U.S. Department of Justice, ruling that Humana can use those admissions in one of the first bellwether trials in sprawling multidistrict litigation.
-
July 27, 2026
Regeneron told a Delaware federal court the recent regulatory approval of a new cholesterol drug is irrelevant to its case accusing Amgen of bundling Repatha with other medications, as the court mulls an injunction bid following Regeneron's $407 million jury win.
-
July 24, 2026
Early-stage biotechnology firm Scribe Therapeutics began trading publicly on Friday after raising $129 million in its upsized initial public offering steered by Fenwick & West LLP and Latham & Watkins LLP.